150 related articles for article (PubMed ID: 38068514)
1. Prognostic Value of Holter Monitoring in Light Chain Amyloidosis.
Sun Y; Zhao Q; Liu Y; Wen L; Dou X; Lu J; Liu J
J Clin Med; 2023 Dec; 12(23):. PubMed ID: 38068514
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis.
Sidana S; Tandon N; Brady PA; Grogan M; Gertz MA; Dispenzieri A; Lin G; Dingli D; Buadi FK; Lacy MQ; Kapoor P; Gonsalves WI; Muchtar E; Warsame R; Kumar SK; Kourelis TV
Mayo Clin Proc; 2019 Mar; 94(3):455-464. PubMed ID: 30718070
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of premature ventricular contractions and non-sustained ventricular tachycardia in light-chain cardiac amyloidosis.
Chen Z; Shi A; Dong H; Laptseva N; Chen F; Yang J; Guo X; Duru F; Chen K; Chen L
Europace; 2024 Mar; 26(3):. PubMed ID: 38466042
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for patients with systemic light chain amyloidosis and Mayo stage 3B disease.
Theodorakakou F; Briasoulis A; Fotiou D; Petropoulos I; Georgiopoulos G; Lama N; Kelekis N; Repasos E; Migkou M; Stamatelopoulos K; Dimopoulos MA; Kastritis E
Hematol Oncol; 2023 Oct; 41(4):725-732. PubMed ID: 36974438
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation.
Al Saleh AS; Sidiqi MH; Muchtar E; Buadi FK; Dispenzieri A; Warsame R; Lacy MQ; Dingli D; Gonsalves WI; Kourelis TV; Hogan WJ; Hayman SR; Kapoor P; Kumar SK; Gertz MA
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1402-1405. PubMed ID: 32422250
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Left Ventricular
Clerc OF; Datar Y; Cuddy SA; Bianchi G; Taylor A; Benz DC; Robertson M; Kijewski MF; Jerosch-Herold M; Kwong RY; Ruberg FL; Liao R; Di Carli MF; Falk RH; Dorbala S
medRxiv; 2023 Sep; ():. PubMed ID: 37745589
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
8. Rapid Device-Detected Nonsustained Ventricular Tachycardia in the Risk Stratification of Hypertrophic Cardiomyopathy.
Viswanathan K; Suszko AM; DAS M; Jackson N; Gollob M; Cameron D; Spears D; Woo A; Rakowski H; Khurana M; Chauhan VS
Pacing Clin Electrophysiol; 2016 Jul; 39(7):642-51. PubMed ID: 27027856
[TBL] [Abstract][Full Text] [Related]
9. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
Hirakawa K; Takashio S; Marume K; Yamamoto M; Hanatani S; Yamamoto E; Sakamoto K; Izumiya Y; Kaikita K; Oda S; Utsunomiya D; Shiraishi S; Ueda M; Yamashita T; Yamashita Y; Ando Y; Tsujita K
ESC Heart Fail; 2019 Feb; 6(1):122-130. PubMed ID: 30284755
[TBL] [Abstract][Full Text] [Related]
10. Holter monitoring in AL amyloidosis: prognostic implications.
Palladini G; Malamani G; Cò F; Pistorio A; Recusani F; Anesi E; Garini P; Merlini G
Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1228-33. PubMed ID: 11523608
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic value of left ventricular mass index in patients with light-chain amyloidosis.
Huang H; He H; Qin Y; Du J; Song J
Acta Cardiol; 2022 Nov; 77(9):815-821. PubMed ID: 36196999
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
[TBL] [Abstract][Full Text] [Related]
13. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients.
Monserrat L; Elliott PM; Gimeno JR; Sharma S; Penas-Lado M; McKenna WJ
J Am Coll Cardiol; 2003 Sep; 42(5):873-9. PubMed ID: 12957435
[TBL] [Abstract][Full Text] [Related]
14. Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL).
Tandon N; Sidana S; Dispenzieri A; Gertz MA; Lacy MQ; Dingli D; Buadi FK; Fonder AL; Hayman SR; Hwa YL; Hobbs MA; Kapoor P; Gonsalves WI; Leung N; Go RS; Lust JA; Russell SJ; Kyle RA; Rajkumar SV; Kumar SK
Am J Hematol; 2018 Jan; 93(1):17-22. PubMed ID: 28960427
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy.
Zecchin M; Di Lenarda A; Gregori D; Moretti M; Driussi M; Aleksova A; Chersevani D; Sabbadini G; Sinagra G
Ital Heart J; 2005 Sep; 6(9):721-7. PubMed ID: 16212073
[TBL] [Abstract][Full Text] [Related]
16. The risk of non-sustained ventricular tachycardia after percutaneous alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Klopotowski M; Chojnowska L; Malek LA; Maczynska R; Kukula K; Demkow M; Witkowski A; Dabrowski M; Karcz M; Baranowski R; Kusmierczyk-Droszcz B; Kruk M; Jamiolkowski J; Kusmierczyk M; Szumowski L; Ruzyllo W
Clin Res Cardiol; 2010 May; 99(5):285-92. PubMed ID: 20148331
[TBL] [Abstract][Full Text] [Related]
17. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
[TBL] [Abstract][Full Text] [Related]
18. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis.
Gustine JN; Staron A; Mendelson L; Joshi T; Gopal DM; Siddiqi OK; Ruberg FL; Sanchorawala V
Blood Adv; 2023 Oct; 7(20):6080-6091. PubMed ID: 37581513
[TBL] [Abstract][Full Text] [Related]
19. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation.
Sidiqi MH; Aljama MA; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dispenzieri A; Dingli D; Leung N; Gonsalves WI; Kumar SK; Kapoor P; Kourelis TV; Hogan WJ; Gertz MA
Blood Adv; 2018 Apr; 2(7):769-776. PubMed ID: 29615413
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.
Pun SC; Landau HJ; Riedel ER; Jordan J; Yu AF; Hassoun H; Chen CL; Steingart RM; Liu JE
J Am Soc Echocardiogr; 2018 Jan; 31(1):64-70. PubMed ID: 29111123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
